Latest News

These regulations would further the "right-to-know" purposes of the statute and provide more specific guidance on the content of safe harbor warnings for a variety of exposure situations, and corresponding methods for providing those warnings. It also would add a specific section to the regulations addressing the relative responsibilities for providing warnings for businesses in the chain of commerce versus retail sellers of a given product.

OEHHA hereby gives notice that it has decided not to proceed with the rulemaking action published in the CRNR on January 16, 2015.

Comment Period for a Safe Use Determination for diisononyl phthalate (DINP) in Tandus Centiva ER3® modular vinyl carpet tile

Notice of proposed rulemaking and public hearing for a regulation to establish a framework for a website operated by OEHHA that would provide information to the public about potential exposures to listed chemicals.

2015 proposal to adopt a No Significant Risk Level (NSRL) of 146 micrograms per day for diisononyl phthalate (DINP), by amending Title 27, California Code of Regulations, section 25705(b).

Structure of the Cholinesterase Monitoring Program

Services Available from OEHHA to the General Public, to Health Care Providers, and to Counties and other government agencies.

Effective December 26, 2014, the Office of Environmental Health Hazard Assessment (OEHHA) is adding dibenzanthracenes (as a chemical group), dibenz[a,c]anthracene, and dibenz[a,j]anthracene to the list of chemicals known to the state to cause cancer.

Public comment period (through March 11, 2015) on the proposal to adopt a Proposition 651 No Significant Risk Level (NSRL) of 146 micrograms per day for diisononyl phthalate (DINP), by amending Title 27, California Code of Regulations, section 25705(b)

RFCI requests OEHHA to determine that exposures to DINP in vinyl flooring products do not present significant cancer risks under Proposition 65, and do not require a warning. The basis for the request is that RFCI estimates the potential lifetime average daily exposures from inhalation, ingestion, and dermal absorption to installers and consumers would be below the level posing no significant risk, as defined in section 25703. This SUD request is limited to exposures to DINP only.